Gelonghui May 8 丨 Jincheng Pharmaceutical (300233)(300233therubymegaways.SZ) said on the investor interaction platformtherubymegaways, the company has been deeply involved in the field of synthetic biology for many yearstherubymegaways, has established an internationally leading synthetic biology industrialization platform, and has successfully implemented biosynthetic products such as glutathione, adenosylmethionine, astaxanthin, and PQQ, as well as enzymatic catalytic products such as 4-AA and nicotine. The company has established close industry-university-research cooperation and platform co-construction with authoritative teams in the field, forming a complete synthetic biology industry chain from upstream research and development, pilot scale expansion to industrialization. Currently, there are many products under research, and the company will actively promote the progress of product research and development to achieve industrialization as soon as possible.